Connect with us

Hi, what are you looking for?

Uncategorized

Marketmind: Soft landing swings into view

© Reuters. FILE PHOTO: The headquarters of the European Central Bank (ECB) is illuminated with a giant euro sign at the start of the “Luminale, light and building” event in Frankfurt, Germany, March 12, 2016. REUTERS/Kai Pfaffenbach//File Photo

A look at the day ahead in European and global markets from Brigid Riley

Is the most aggressive U.S. hiking cycle in a generation finished? After Wednesday’s 25 basis point hike, markets seem to think so.

Traders in Asia cheered a glimpse of the fabled soft landing with Jerome Powell saying the Fed no longer expects a U.S. recession. Stocks rose and the dollar fell across the board. The spotlight now falls on Christine Lagarde and the European Central Bank, which is all but certain to follow with an additional quarter of a percentage point hike later today.

The focus will be on President Lagarde’s tone and language for a guide on what’s to come – with the outlook likely to move the euro and set the dollar’s direction.

Markets had expected hawkishness, but were set aflutter last week when council member Klass Knot cast doubt on the need for hikes beyond July.

The Bank of Japan is then up on Friday, with perhaps the most unpredictable central bank decision of the week. The yen hit the strong side of 140 to the dollar as nobody wants to be caught short if there’s a surprise tweak to yield controls.

European futures rose 0.3% and U.S. futures also added 0.3%.

On the earnings front, Renault (EPA:), TotalEnergies (EPA:) and L’Oreal (EPA:) report in France and Intel (NASDAQ:), Ford (NYSE:), Mastercard (NYSE:), and McDonald’s (NYSE:) in the United States.

Stimulus hopes drove Chinese stocks higher on Thursday, with the up 1.4%, and its tech subindex gaining 3% and property stocks over 4%.

Key developments that could influence markets on Thursday: – ECB rate decision

– U.S. preliminary Q2 GDP numbers

– U.S. initial jobless claims

– U.S. June durable goods data

 

 

 

 

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

This article was written by Follow Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech...

Videos

Watch full video on YouTube